These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 276621

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions.
    Watanabe K, Williams GM.
    J Natl Cancer Inst; 1978 Nov; 61(5):1311-4. PubMed ID: 280716
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action.
    Furuya K, Maeura Y, Williams GM.
    Toxicol Pathol; 1984 Nov; 12(2):136-42. PubMed ID: 11478314
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nature of early appearing, carcinogen-induced liver lesions to iron accumulation.
    Williams GM, Klaiber M, Parker SE, Farber E.
    J Natl Cancer Inst; 1976 Jul; 57(1):157-65. PubMed ID: 1003498
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sequential functional and morphological alterations during hepatocarcinogenesis induced in rats by feeding of a low dose of 2-acetylaminofluorene.
    Stenbäck F, Gebhardt R, Sirma H, Garbay JM, Williams GM.
    Toxicol Pathol; 1994 Jul; 22(6):620-32. PubMed ID: 7732279
    [Abstract] [Full Text] [Related]

  • 13. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
    Merritt WD, Richardson CL, Keenan TW, Morré DJ.
    J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. DNA content of liver cell nuclei of N-2-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci.
    Mori H, Tanaka T, Sugie S, Takahashi M, Williams GM.
    J Natl Cancer Inst; 1982 Dec; 69(6):1277-82. PubMed ID: 6958905
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhancing effect of barbital on N-2-fluorenylacetamide-induced rat liver lesions.
    Mori H, Tanaka T, Nishikawa A, Takahashi M, Williams GM.
    Gan; 1981 Oct; 72(5):798-801. PubMed ID: 7327380
    [Abstract] [Full Text] [Related]

  • 18. Nuclear inclusions and other ultrastructural aspects in the liver of animals treated with n-2-acetylaminofluorene.
    Dobre MA, Moraru I, Cotutiu C, Moţoc F.
    Pathol Eur; 1976 Oct; 11(1):63-8. PubMed ID: 934702
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.